BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 16774941)

  • 1. Genistein protects prostate cells against hydrogen peroxide-induced DNA damage and induces expression of genes involved in the defence against oxidative stress.
    Raschke M; Rowland IR; Magee PJ; Pool-Zobel BL
    Carcinogenesis; 2006 Nov; 27(11):2322-30. PubMed ID: 16774941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using DNA microarray analyses to elucidate the effects of genistein in androgen-responsive prostate cancer cells: identification of novel targets.
    Takahashi Y; Lavigne JA; Hursting SD; Chandramouli GV; Perkins SN; Barrett JC; Wang TT
    Mol Carcinog; 2004 Oct; 41(2):108-119. PubMed ID: 15378649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genistein and daidzein induce cell proliferation and their metabolites cause oxidative DNA damage in relation to isoflavone-induced cancer of estrogen-sensitive organs.
    Murata M; Midorikawa K; Koh M; Umezawa K; Kawanishi S
    Biochemistry; 2004 Mar; 43(9):2569-77. PubMed ID: 14992594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced isoflavone metabolites formed by the human gut microflora suppress growth but do not affect DNA integrity of human prostate cancer cells.
    Raschke M; Wähälä K; Pool-Zobel BL
    Br J Nutr; 2006 Sep; 96(3):426-34. PubMed ID: 16925846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genistein inhibits NF-kappa B activation in prostate cancer cells.
    Davis JN; Kucuk O; Sarkar FH
    Nutr Cancer; 1999; 35(2):167-74. PubMed ID: 10693171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular signatures of soy-derived phytochemicals in androgen-responsive prostate cancer cells: a comparison study using DNA microarray.
    Takahashi Y; Lavigne JA; Hursting SD; Chandramouli GV; Perkins SN; Kim YS; Wang TT
    Mol Carcinog; 2006 Dec; 45(12):943-56. PubMed ID: 16865672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of the growth inhibitory effects of the isoflavonoid biochanin A on LNCaP cells and xenografts.
    Rice L; Samedi VG; Medrano TA; Sweeney CA; Baker HV; Stenstrom A; Furman J; Shiverick KT
    Prostate; 2002 Aug; 52(3):201-12. PubMed ID: 12111696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential amplification of gene expression in lens cell lines conditioned to survive peroxide stress.
    Spector A; Li D; Ma W; Sun F; Pavlidis P
    Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3251-64. PubMed ID: 12356832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentration-dependent effects of genistein on global gene expression in MCF-7 breast cancer cells: an oligo microarray study.
    Lavigne JA; Takahashi Y; Chandramouli GV; Liu H; Perkins SN; Hursting SD; Wang TT
    Breast Cancer Res Treat; 2008 Jul; 110(1):85-98. PubMed ID: 17687646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular DNA breakage by soy isoflavone genistein and its methylated structural analogue biochanin A.
    Ullah MF; Shamim U; Hanif S; Azmi AS; Hadi SM
    Mol Nutr Food Res; 2009 Nov; 53(11):1376-85. PubMed ID: 19743405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soy phytoestrogens modify DNA methylation of GSTP1, RASSF1A, EPH2 and BRCA1 promoter in prostate cancer cells.
    Vardi A; Bosviel R; Rabiau N; Adjakly M; Satih S; Dechelotte P; Boiteux JP; Fontana L; Bignon YJ; Guy L; Bernard-Gallon DJ
    In Vivo; 2010; 24(4):393-400. PubMed ID: 20668305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soy isoflavones protect the intestine from lipid hydroperoxide mediated oxidative damage.
    Wijeratne SS; Cuppett SL
    J Agric Food Chem; 2007 Nov; 55(24):9811-6. PubMed ID: 17960878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between daidzein and genistein antioxidant activity in primary and cancer lymphocytes.
    Foti P; Erba D; Riso P; Spadafranca A; Criscuoli F; Testolin G
    Arch Biochem Biophys; 2005 Jan; 433(2):421-7. PubMed ID: 15581598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones.
    Guo Y; Wang S; Hoot DR; Clinton SK
    J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Butyrate may enhance toxicological defence in primary, adenoma and tumor human colon cells by favourably modulating expression of glutathione S-transferases genes, an approach in nutrigenomics.
    Pool-Zobel BL; Selvaraju V; Sauer J; Kautenburger T; Kiefer J; Richter KK; Soom M; Wölfl S
    Carcinogenesis; 2005 Jun; 26(6):1064-76. PubMed ID: 15746163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic and epigenetic regulations of prostate cancer by genistein.
    Molinié B; Georgel P
    Drug News Perspect; 2009 Jun; 22(5):247-54. PubMed ID: 19609462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in gene expressions elicited by physiological concentrations of genistein on human endometrial cancer cells.
    Konstantakopoulos N; Montgomery KG; Chamberlain N; Quinn MA; Baker MS; Rice GE; Georgiou HM; Campbell IG
    Mol Carcinog; 2006 Oct; 45(10):752-63. PubMed ID: 16705744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress induces ADAM9 protein expression in human prostate cancer cells.
    Sung SY; Kubo H; Shigemura K; Arnold RS; Logani S; Wang R; Konaka H; Nakagawa M; Mousses S; Amin M; Anderson C; Johnstone P; Petros JA; Marshall FF; Zhau HE; Chung LW
    Cancer Res; 2006 Oct; 66(19):9519-26. PubMed ID: 17018608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced expression of glutathione-S-transferase A1-1 protects against oxidative stress in human retinal pigment epithelial cells.
    Liang FQ; Alssadi R; Morehead P; Awasthi YC; Godley BF
    Exp Eye Res; 2005 Jan; 80(1):113-9. PubMed ID: 15652532
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Agents used for chemoprevention of prostate cancer may influence PSA secretion independently of cell growth in the LNCaP model of human prostate cancer progression.
    Peternac D; Klima I; Cecchini MG; Schwaninger R; Studer UE; Thalmann GN
    Prostate; 2008 Sep; 68(12):1307-18. PubMed ID: 18512728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.